Truist Securities Reiterates Buy on Incyte, Maintains $91 Price Target
Portfolio Pulse from Benzinga Newsdesk
Truist Securities analyst Srikripa Devarakonda has reiterated a Buy rating on Incyte (NASDAQ:INCY) and maintained a $91 price target for the company's stock.
November 29, 2023 | 6:13 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Truist Securities analyst Srikripa Devarakonda reaffirmed a Buy rating on Incyte with a steady price target of $91, indicating a positive outlook for the stock.
The reiteration of a Buy rating and the maintenance of a price target by a reputable analyst like Srikripa Devarakonda from Truist Securities typically instills confidence in investors and can lead to a positive short term impact on the stock price. The specific mention of the $91 price target suggests a potential upside from the current trading level, assuming the market aligns with the analyst's valuation.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100